Andrew Embleton-Thirsk

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 2

Top Topics

Diffuse Large B Cell Lymphoma

Systemic Lupus Erythematosus

Randomized Controlled Trial

Top Venues

Annals of internal medicine

Clinical trials (London, England)

University College London (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University College London Mar 01 2017

United Kingdom

PHD :: Institute of Clinical Trials and Methodology

London School of Hygiene and Tropical Medicine Oct 01 2011 - Jul 01 2012

United Kingdom

MSC

University of Reading Sep 01 2004 - Jul 01 2008

United Kingdom

BSC

Publications

Muhammad Ruhul Amin Shipa, Andrew Embleton-Thirsk, Mariea Parvaz, Liliana Ribeiro Santos, Patrick Muller, Kashfia Chowdhury, David A Isenberg, Caroline J Doré, Caroline Gordon, Michael R Ehrenstein, null null
Effectiveness of Belimumab After Rituximab in Systemic Lupus Erythematosus : A Randomized Controlled Trial. Annals of internal medicine (2021)
Andrew Embleton-Thirsk, Elizabeth Deane, Stephen Townsend, Laura Farrelly, Babasola Popoola, Judith Parker, Gordon Rustin, Matthew Robert Sydes, Mahesh Parmar, Jonathan Ledermann, Richard Kaplan
Impact of retrospective data verification to prepare the ICON6 trial for use in a marketing authorization application. Clinical trials (London, England) 16 (5) (2019)